HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report

HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.

Detalles Bibliográficos
Autores principales: Yasuda, Taisei, Osaki, Masami, Sugitani, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593971/
https://www.ncbi.nlm.nih.gov/pubmed/37881200
http://dx.doi.org/10.1002/ccr3.8099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593971/
https://www.ncbi.nlm.nih.gov/pubmed/37881200
http://dx.doi.org/10.1002/ccr3.8099

Ejemplares similares